Bernhard Ortel to Pyrimidines
This is a "connection" page, showing publications Bernhard Ortel has written about Pyrimidines.
Connection Strength
0.055
-
The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model. Oncogene. 2002 Mar 27; 21(13):2089-96.
Score: 0.043
-
Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats. Prostate. 2003 Feb 15; 54(3):206-11.
Score: 0.011